Sangamo Therapeutics (NASDAQ:SGMO) reported Q1 2018 earnings this Morning, coming in at ($0.23) per share, missing Wall Street’s estimates of ($0.16) per Share. Revenue for the quarter came in at $12.60 million missing the streets estimates of $53.09 million Recent Insider Trading for Sangamo Therapeutics (NASDAQ:SGMO)
- On 4/16/2018 Kathy Yi, CFO, sold 5,000 with an average share price of $19.83 per share and the total transaction amounting to $99,150.00.
- On 4/13/2018 Curt A Herberts III, VP, sold 8,163 with an average share price of $20.00 per share and the total transaction amounting to $163,260.00.
- On 4/6/2018 Edward R. Conner, VP, sold 5,000 with an average share price of $17.41 per share and the total transaction amounting to $87,050.00.
- On 4/2/2018 Curt A Herberts III, VP, sold 2,278 with an average share price of $18.30 per share and the total transaction amounting to $41,687.40.
- On 4/2/2018 Steven J Mento, Director, sold 7,215 with an average share price of $18.40 per share and the total transaction amounting to $132,756.00.
- On 3/15/2018 Kathy Yi, CFO, sold 5,000 with an average share price of $25.56 per share and the total transaction amounting to $127,800.00.
Dividend History for Sangamo Therapeutics (NASDAQ:SGMO)
Recent Trading for Sangamo Therapeutics (NASDAQ:SGMO) Shares of Sangamo Therapeutics closed the previous trading session at 16.10 down -0.15 0.92% with 16.149999618530273 shares trading hands.